CJC-1295 & Ipamorelin Pen

CJC-1295 & Ipamorelin – Research Peptide Blend

This research blend combines CJC-1295 and Ipamorelin, two synthetic peptides studied for their role in growth hormone signalling, pituitary function, IGF-1-related pathways, metabolic research, recovery biology, and body-composition studies.

CJC-1295 is a growth hormone-releasing hormone analogue investigated for its interaction with pituitary growth hormone release pathways. Ipamorelin is a selective growth hormone secretagogue studied for its role in supporting growth hormone-related signalling through targeted receptor activity.

Together, CJC-1295 and Ipamorelin are of interest in research models exploring growth hormone axis regulation, protein-synthesis pathways, tissue repair, recovery mechanisms, fat-metabolism research, sleep-related endocrine rhythms, and age-related biological processes.

It is supplied strictly for laboratory and research purposes only and is not intended for human consumption, medical use, diagnosis, treatment, or prevention of any disease.